Covered recipient · General Payments record
CARLOS MAURICIO MILLAN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Epilepsy
General Payments · PY2022–2024
$3,984.71
- Reported across 53 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,763.96 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $719.89 | 11 |
| LivaNova USA, Inc. | $278.17 | 5 |
| Neurelis, Inc. | $259.98 | 6 |
| ABBVIE INC. | $214.33 | 5 |
| JAZZ PHARMACEUTICALS INC. | $199.69 | 3 |
| PFIZER INC. | $43.87 | 2 |
| SK Life Science, Inc. | $30.76 | 1 |
| NEUROPACE, INC. | $17.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $30.00 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105034993 | CMS |
| ABBVIE INC. | $115.25 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105034995 | CMS |
| ABBVIE INC. | $20.00 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105034997 | CMS |
| ABBVIE INC. | $23.75 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105034999 | CMS |
| ABBVIE INC. | $25.33 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035001 | CMS |
| JAZZ PHARMACEUTICALS INC. | $129.60 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150241294 | CMS |
| JAZZ PHARMACEUTICALS INC. | $24.26 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150241296 | CMS |
| JAZZ PHARMACEUTICALS INC. | $45.83 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150241298 | CMS |
| LivaNova USA, Inc. | $132.26 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152788143 | CMS |
| LivaNova USA, Inc. | $21.28 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152788193 | CMS |
| LivaNova USA, Inc. | $1.72 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152788195 | CMS |
| LivaNova USA, Inc. | $24.82 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152788197 | CMS |
| LivaNova USA, Inc. | $98.09 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152788221 | CMS |
| Neurelis, Inc. | $27.08 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145648326 | CMS |
| Neurelis, Inc. | $24.96 | 10/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145648328 | CMS |
| Neurelis, Inc. | $45.68 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145648330 | CMS |
| Neurelis, Inc. | $14.03 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145648332 | CMS |
| Neurelis, Inc. | $2.52 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145648334 | CMS |
| Neurelis, Inc. | $145.71 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145648336 | CMS |
| NEUROPACE, INC. | $17.27 | 10/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153272808 | CMS |
| PFIZER INC. | $21.65 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131582982 | CMS |
| PFIZER INC. | $22.22 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131556966 | CMS |
| SK Life Science, Inc. | $30.76 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154139166 | CMS |
| UCB, Inc. | $132.27 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143358591 | CMS |
| UCB, Inc. | $62.15 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143358595 | CMS |
| UCB, Inc. | $72.61 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143358599 | CMS |
| UCB, Inc. | $16.27 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143358604 | CMS |
| UCB, Inc. | $33.48 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143358608 | CMS |
| UCB, Inc. | $28.94 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143358613 | CMS |
| UCB, Inc. | $107.33 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143358617 | CMS |
| UCB, Inc. | $30.80 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143358621 | CMS |
| UCB, Inc. | $48.44 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143358625 | CMS |
| UCB, Inc. | $124.98 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143358630 | CMS |
| UCB, Inc. | $62.62 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143358634 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.